Effects of three different topical antibacterial dressings on Acinetobacter baumannii-contaminated full-thickness burns in rats.

[1]  H. Moghimi,et al.  Enhancing drugs absorption through third-degree burn wound eschar. , 2008, Burns : journal of the International Society for Burn Injuries.

[2]  H. Chim,et al.  Five-year review of infections in a burn intensive care unit: High incidence of Acinetobacter baumannii in a tropical climate. , 2007, Burns : journal of the International Society for Burn Injuries.

[3]  B. R. Sharma,et al.  Infection in patients with severe burns: causes and prevention thereof. , 2007, Infectious disease clinics of North America.

[4]  J. stephen-Haynes,et al.  Assessment and management of wound infection: the role of silver. , 2007, British journal of community nursing.

[5]  C. Schulman,et al.  Outcomes of Acinetobacter baumannii Infection in Critically Ill Burned Patients , 2007, Journal of burn care & research : official publication of the American Burn Association.

[6]  Bishara S Atiyeh,et al.  Effect of silver on burn wound infection control and healing: review of the literature. , 2007, Burns : journal of the International Society for Burn Injuries.

[7]  Fiona Wood,et al.  Nanocrystalline silver dressings in wound management: a review , 2006, International journal of nanomedicine.

[8]  D. Church,et al.  Burn Wound Infections , 2006, Clinical Microbiology Reviews.

[9]  V. Poon,et al.  Antimicrobial activities of silver dressings: an in vitro comparison. , 2006, Journal of medical microbiology.

[10]  O. Oncul,et al.  Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and fusidic acid 2% (Fucidin) for topical antibacterial effect in methicillin-resistant Staphylococci-contaminated, full-skin thickness rat burn wounds. , 2005, Burns : journal of the International Society for Burn Injuries.

[11]  Ş. Çavuşlu,et al.  Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and silver sulfadiazine 1% (Silverdin) for topical antibacterial effect in Pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats. , 2005, The Journal of burn care & rehabilitation.

[12]  S. Percival,et al.  Bacterial resistance to silver in wound care. , 2005, The Journal of hospital infection.

[13]  M. Vaneechoutte,et al.  Species-Level Identification of Isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii Complex by Sequence Analysis of the 16S-23S rRNA Gene Spacer Region , 2005, Journal of Clinical Microbiology.

[14]  J. Kucan,et al.  The Potential Benefit of 5% Sulfamylon Solution in the Treatment of Acinetobacter baumannii–contaminated Traumatic War Wounds , 2005, Journal of burns and wounds.

[15]  K. Dunn,et al.  The role of Acticoat with nanocrystalline silver in the management of burns. , 2004, Burns : journal of the International Society for Burn Injuries.

[16]  R. Kimble,et al.  An in vitro study of the anti-microbial efficacy of a 1% silver sulphadiazine and 0.2% chlorhexidine digluconate cream, 1% silver sulphadiazine cream and a silver coated dressing. , 2004, Burns : journal of the International Society for Burn Injuries.

[17]  C. Dowsett.  An overview of Acticoat dressing in wound management. , 2003, British journal of nursing.

[18]  A. Levin,et al.  Infections in a burn intensive care unit: experience of seven years. , 2003, The Journal of hospital infection.

[19]  A. Lansdown,et al.  Silver. I: Its antibacterial properties and mechanism of action. , 2002, Journal of wound care.

[20]  E. Hidalgo,et al.  Mechanisms underlying chlorhexidine-induced cytotoxicity. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[21]  S. Lang,et al.  Investigation of an outbreak of multi-drug resistant Acinetobacter baumannii in an intensive care burns unit. , 2001, The Journal of hospital infection.

[22]  P. Shivananda,et al.  Acinetobacter baumannii--an emerging nosocomial pathogen in the burns unit Manipal, India. , 2001, Burns : journal of the International Society for Burn Injuries.

[23]  B. Cunha,et al.  Acinetobacter baumanii-associated arterial line infection. , 2000, American journal of infection control.

[24]  R. Burrell,et al.  Efficacy of topical silver against fungal burn wound pathogens. , 1999, American journal of infection control.

[25]  O. Lyytikäinen,et al.  Outbreak caused by two multi-resistant Acinetobacter baumannii clones in a burns unit: emergence of resistance to imipenem. , 1995, The Journal of hospital infection.

[26]  E. Bergogne-Bérézin.  The increasing significance of outbreaks of Acinetobacter spp.: the need for control and new agents. , 1995, The Journal of hospital infection.

[27]  E. Lowbury,et al.  Drug resistance in relation to use of silver sulphadiazine cream in a burns unit. , 1977, Journal of clinical pathology.

[28]  A. F. Peterson,et al.  Safety and efficacy of the antiseptic chlorhexidine gluconate. , 1976, Surgery, gynecology & obstetrics.

[29]  A. Mason,et al.  A standard animal burn. , 1968, The Journal of trauma.